Simon Kerridge
Quality Assurance Manager
Simon Kerridge works as the Quality Assurance Manager for the clinical trials vaccine groups within Oxford University. Originally trained in microbiology, he moved into the quality management field after working in the pharmaceutical industry. Over the past 10 years he has developed and operated quality systems within the NHS and university environment, providing a practical approach to quality improvement. At Oxford Vaccine Group, Simon ensures that procedures and processes are in place to maintain the high standard of clinical trials conducted.
Recent publications
-
The Impact of Infant Bacille Calmette-Guérin Vaccination on the Immunogenicity of Other Vaccines: A Randomized Exploratory Study.
Journal article
Maytum A. et al, (2024), Pediatr Infect Dis J
-
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
Journal article
Ramasamy MN. et al, (2021), Lancet, 396, 1979 - 1993
-
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).
Journal article
Flaxman A. et al, (2021), Lancet, 398, 981 - 990